In this issue of the Journal, Klassen et al. report that thenebulized glucocorticoid budesonide produces prompt and substantialclinical improvement in children who present to the emergencyroom with mild-to-moderate croup1. These authors report fasterdischarge from the emergency room and a reduced rate of subsequentadmission to the hospital. However, there was subsequent useof dexamethasone in both the budesonide group and the placebogroup, an indication that the attending physicians continuedto be concerned about their patients.
Although viral croup is the most common upper airway diseasein children in the first four years of life, . . . [Full Text of this Article]
Previous
